Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Open-label Phase II Trial Evaluating the Safety and Efficacy of Ponatinib Induction Followed by Imatinib Maintenance in Adult Patients With Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) ≤ 65 Years

NCT04070443 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT04070443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04070443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Open-label Phase II Trial Evaluating the Safety and Efficacy of Ponatinib Induction Followed by Imatinib Maintenance in Adult Patients With Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) ≤ 65 Years
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 13, 2019
Completion date
June 1, 2029
Enrollment
170 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

bcr-abl positive chronic myelogenous leukemia, philadelphia chromosome positive cml